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In IgG4-related urinary tract diseases, the renal pelvis and ureters are rarely involved; 
however, the number of reported cases with this involvement has been increasing. 
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IgG4-related renal pelvic and ureteral lesions accompany extra-renal organ involvement, 
including IgG4-related type 1 autoimmune pancreatitis, and are characterized by 
common pathological features of IgG4-related diseases, including substantial numbers 
of IgG4-positive plasma cells, sclerosing fibrosis, and stenosis in the affected organs. 
Similar to other mucosal organs affected in IgG4-related disease, these inflammatory 
findings are observed within the fibroadipose tissue in the renal hilum and around the 
ureters, and the urothelial epithelium covering the renal pelvis and ureter is preserved. 
Nodular lesions such as pseudotumors can also form and it is important to differentiate 
these from malignant tumors. At present, comprehensive diagnostic criteria that include 
pathological parameters have been proposed for IgG4-related diseases; however, 
obtaining diagnostic findings in small biopsy specimens is usually challenging. 
Therefore, the diagnosis must be made on a case-by-case basis, with careful 
consideration of the clinical, serologic, radiologic, and pathologic features in light of the 
potential manifestations of IgG4-related disease in other organs. 
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1. Introduction 
 Hamano et al. (1) first reported the presence of elevated serum IgG4 concentrations in 
autoimmune pancreatitis (AIP) patients as a prototype of IgG4-related diseases in 2001, 
and Kamisawa et al. (2) proposed the existence of IgG4-related systemic disease as a 
new clinicopathologic entity affecting a wide variety of organs in 2003. Increased serum 
IgG4 levels (>135 mg/dl), the presence of IgG4-positive cells in affected organs, and 
effective disease control with steroid treatment are unique clinicopathological features 
of IgG4-related diseases, irrespective of the affected organs; however, additional 
organ-specific histological findings are frequently observed. In particular, IgG4-related 
kidney disease encompasses renal and renal pelvic lesions, and tubulointerstitial 
nephritis in the renal cortex is a well-described, major manifestation of the disease. 
However, the glomeruli, renal pelvis, and ureter are also affected in IgG4-related renal 
diseases, mostly in association with retroperitoneal fibrosis. Moreover, 
pseudotumor-like nodular lesions mimicking urothelial carcinoma may also form in the 
renal pelvis and ureter. Most reported cases of IgG4-related kidney diseases have a 
history of prior IgG4-related pancreatitis or sialoadenitis; however, several cases of 
patients with IgG4-related urinary tract disease in the absence of other organ 
involvement have also been reported. In this chapter, renal pelvic and ureteral lesions in 
IgG4-related diseases have been described. 
 
2. Clinical features of renal pelvic and ureteral lesions 
Involvement of the renal pelvis and ureter in IgG4-related diseases is rare. Our review 
of the literature using the search engines for Japanese and English medical articles, 
ICHUSHI (Web. Japana Centra Revuo Medicina) and PubMed, respectively, revealed a 
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total of 35 reported cases of such involvement (3-30), including a renal pelvic case that 
was reported by our group (Case 12); all cases are summarized in Table 1. In addition, a 
review article on IgG4-related renal diseases has recently been reported (31). The age of 
patients ranged from 39 to 84 years, and older patients as well as males constituted the 
majority. Most of the cases involved isolated renal pelvic or ureter diseases; however, 
continuous distributions from the pelvic to the ureter as well as inflammatory 
pseudotumors were also observed in some cases. Moreover, synchronous and 
metachronous involvement was found in bilateral pelvises and ureters. In all cases the 
serum IgG4 levels were found to be above 135 mg/dl, with the exception of one case in 
which the serum IgG4 levels were analyzed after the operation. Retroperitoneal fibrosis 
as well as autoimmune pancreatitis is often accompanied with IgG4-related renal pelvic 
and ureteral diseases. 
 
3. Renal pelvic lesions 
The renal pelvic lesions of IgG4-related diseases are radiologically visualized as 
thickening of the renal pelvic wall without luminal irregularity and tumorous lesions in 
the renal hilum. As shown in Figures 1–3, unlike renal pelvic mucosal lesions, the 
lesions in IgG4-related kidney diseases are recognizable as nonspecific nodular lesions 
within the fibroadipose tissue of the renal hilum. The disease histology shows dense 
lymphoplasmacytic infiltration of the lymphoid follicle and loss of adipose tissue within 
the renal hilum. Sclerosing fibrosis with occasional hyalinization and storiform and 
swirling fibrosis are found (Fig. 3F). However, the degree of sclerosing changes is 
comparatively milder than that observed in autoimmune pancreatitis, a prototypical 
IgG4-related disease; furthermore, some cases show only a prominent inflammatory 
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change without any sclerosing changes (Case 11 in Table 1) (13). Similar to the 
histological characteristics of other affected organs in IgG4-related diseases, 
eosinophilic infiltration, obliterative phlebitis (Fig. 1E), and perineural inflammatory 
infiltration (Fig. 3D) are also observed in some cases. This infiltration extends beyond 
the subepithelial layer of the renal pelvic urothelial mucosa; however, involvement of 
the urinary epithelial layer and epithelial injury are not prominent. Similar to 
IgG4-related autoimmune pancreatitis and sclerosing cholangitis, therefore, epithelial 
layer is well-preserved without any erosive changes. This lack of epithelial layer 
involvement underlies the general difficulties in obtaining valuable pathological 
information from superficial mucosal specimens by renal pelvic biopsy procedures. 
However, specimens from most of the patients show an absence of inflammation 
extending into the renal parenchyma, with a clear border between the renal pelvic 
pathology and renal parenchyma, in some cases, inflammatory invasion of the renal 
parenchyma (Fig. 3) and interstitinal nephritis were observed (Case 3 in Table 1) (5). 
Immunohistochemical staining for IgG4 has revealed substantial numbers of diffuse 
IgG4-positive cells in inflammatory lesions even though IgG4 is a minor 
immunoglobulin subtype comprising only 3%–6% of the total circulating IgG in adults 
(1). In cases with prominent lymphoid follicle formation, IgG4-positive cells tend to be 
localized in the interfollicular area, with several IgG4-positive cells scattered in the 
germinal centers of lymphoid follicles. As expected, these cases fulfill the 
comprehensive pathological diagnostic criteria for IgG4-related disease (32) that is 
based on the presence of >40% of IgG-positive plasma cells as IgG4-positive and the 
presence of >10 cells/high powered field in the biopsy sample. The predominance of 
IgG4-positive cells instead of IgG1-positive cells also supports the diagnosis of 
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IgG4-related diseases (Fig. 2E and F). 
 
3. Ureteral diseases 
 Ureteral involvement in IgG4-related disease has been found in 42% of the 
IgG4-related retroperitoneal fibrosis cases (13). In some patients, renal pelvic 
involvement, as discussed above, or bilateral ureteral lesions are also observed. 
Irrespective of the involvement of other organs, ureteral IgG4-related disease is 
characterized by the thickening of ureteral wall or the presence of nodular lesions 
involving the affected ureter, and these are usually associated with hydronephrosis 
resulting from ureteral stenosis of the affected portion. Therefore, in most IgG4-related 
ureteral cases, the initial presentation is of hydronephrosis associated with 
retroperitoneal fibrosis or renal dysfunction with unknown etiology, and a diagnosis is 
established following the finding of serological data indicating increased serum IgG4 
levels and hypocomplementemia (33). As an example, in one case shown in Table 1 
(Case 10), the definitive diagnosis of IgG4-related ureteral disease was preceded by a 
ureteral calculus (12).  
IgG4-related ureteral disease displays the common pathological features of other 
IgG4-related diseases: in addition to marked lymphoplasmacytic infiltration, 
eosinophilic infiltration and sclerosing fibrosis are also observed in the lesions. 
Advanced fibrosis eventually results in ureteral sclerosis that in turn induces ureteral 
stenosis and obstruction. Lymphoid follicle formation can also be detected, albeit to a 
lesser extent than that observed in renal pelvic lesions. The extension of the 
inflammatory reaction into the adipose tissue around affected organs is an important 
feature of IgG4-related diseases, including autoimmune pancreatitis, reflecting their 
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characteristic radiological findings. Similarly, periureteral fibroadipose tissue as well as 
the ureteral wall harbor inflammatory and fibrosclerotic reactions (Fig. 4A), and in 
some cases, these reactions extend into the lesions of retroperitoneal fibrosis. 
Immunohistochemical staining for IgG1 and IgG4 reveals a predominantly 
IgG4-positive plasma cell infiltration in this disease (Fig. 4D and E). 
 
5. Diagnosis 
The diagnosis of IgG4-related renal pelvic and ureteral diseases is relatively easy and is 
based on the common clinicopathological features of IgG4-related disease in cases 
where there is either a concurrent or preceding diagnosis of IgG4-related disease in 
other organs, such as the pancreas or the salivary glands. However, if the initial lesions 
are within the renal pelvis or ureters with no overt involvement of other organs, 
differentiation of the lesions from malignant masses or stenosis in the affected area is 
crucial. Moreover, inflammatory pseudotumors not related to IgG4, inflammatory 
myofibroblastic tumors (15), and Cattleman’s disease in cases with limited 
fibrosclerosis (13) should also be considered in differential diagnosis.  
 Increased serum IgG4 levels and infiltration of IgG4-positive plasma cells are 
important in the diagnosis of IgG4-related renal pelvic and ureteral diseases. According 
to the current comprehensive diagnostic criteria for IgG4-related disease (32), elevated 
serum levels of IgG4 (≥135 mg/dl) and predominantly IgG4-positive plasma cell 
infiltration (≥10 cells/high-power field with an IgG4-positive:total IgG-positive plasma 
cell ratio of ≥40%) are pathologically necessary for the diagnosis of IgG4-related 
disease. However, as mentioned above, biopsied specimens from the surface of renal 
pelvic and ureteral mucosa are unlikely to contain the characteristic features of 
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IgG4-related disease such as abundance of IgG4-positive cells and sclerosing fibrosis. 
Although the number of IgG4-positive cells that can be detected in small renal pelvic 
and ureteral specimens is not known, the biopsy of stenotic lesions is definitively 
recommended, as demonstrated in Case 13 in Table 1 where the IgG4-related ureteral 
disease was diagnosed by ureteral biopsy (14). 
 To complicate matters, IgG4-related ureteral disease in association with 
carcinoma in situ (urothelial carcinoma) (18), as seen with Case 21 in Table 1, raises the 
possibility of ureteral cancer to precede IgG4-related disease. While the infiltration of 
numerous IgG4-bearing plasma cells is important for the pathogenesis of IgG4-related 
disease, patients with pancreatic adenocarcinomas accompanying IgG4 infiltration in 
the cancerous area and/or elevated serum IgG4 levels (34-38) as well as patients with 
pancreatic and biliary cancers arising from IgG4-related disease (36, 39, 40) have been 
reported. However, a cause-and-effect relationship between IgG4 infiltration and cancer 
is yet to be demonstrated. It is imperative to examine the role of IgG4 in renal pelvic 
and ureteral cancers. Further, potential malignancies should be ruled out before the 
comprehensive criteria for IgG4-related disease are evaluated. Renal pelvic and ureteral 
biopsies and cytological examination are invariably important in the exclusion of 
malignancies prior to the diagnosis of IgG4-related disease. 
 
6. Conclusion 
 Renal pelvic and ureteral lesions associated with IgG4-related disease are rare; 
however, their clinicopathological distinction from malignancy is crucial. In this chapter, 
we reviewed IgG4-related renal pelvic and ureteral diseases in the light of previous 
reports. Consequently, these diseases are often associated with IgG4-related diseases of 
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other organs such as the pancreas and present with increased serum IgG4 levels and 
substantial numbers of IgG4-positive cells in the affected areas that show the typical 
clinicopathological features of IgG4-related disease. Several cases with a potential 
association with malignancy have also been reported. Therefore, care must be taken not 
to be overly influenced by the comprehensive diagnostic criteria because fulfilling them 
does not rule out concomitant cancer. 
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Figure 1. IgG4-related renal pelvic disease (Case 2 in Table 1). A: Macroscopic image 
of the cut surface of the resected kidney. A whitish mass was found in the renal 
hilum. B: Semi-macroscopic image. Asterisk denotes an inflammatory nodular 
lesion resembling a lymphoid organ with a clear border in the renal parenchyma. 
Arrow denotes renal pelvic mucosa. C; Inflammatory lesion containing several 
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lymphoid follicles and marked inflammatory cells. Note that the renal pelvic 
epithelium is well-preserved (arrow). D: Fibrotic area (*) and inflammatory 
invasion into the adipose tissue of the renal pelvis (lower side). E: Arrow denotes 
obliterative phlebitis using Elastica van Gieson staining. F: Numerous 
IgG4-positive cells dispersed throughout the interfollicular area, as determined 
by immunohistochemical staining for IgG4.  
 
Figure 2. IgG4-related renal pelvic disease (Case 12 in Table 1). A: Computed 
tomography showing the presence of a mass within the renal pelvis (arrow). B: 
Semi-macroscopic image of the resected kidney. Lymphoid follicle-like 
inflammatory nodular lesions were found in the renal hilum. The renal pelvic 
mucosa was slit-like indicating stenosis (arrow). C: Renal pelvic mucosa, albeit 
stenotic, was well-preserved with the absence of inflammation (arrow). Fibrosis 
was not prominent. D: Inflammation consisting mostly of lymphocytes and 
plasma cells. E: Immunohistochemical staining for IgG4. Many IgG4-positive 
cells were found in the interfollicular area. F: Semi-serial sectioning of the area 
shown in (E). Immunohistochemical staining for IgG1. Several IgG1-positive 
cells were observed, albeit in smaller numbers than those of the IgG4-positive 
cells observed in (E).  
 
Figure 3. IgG4-related renal pelvic disease (Case 1 in Table 1). A: Macroscopic image 
of the cut surface of the resected kidney. Whitish sclerotic changes were found in 
the adipose tissue of the renal hilum (arrows). B. Semi-macroscopic image of the 
resected kidney. Scar-like, broad fibrosis (*) was prominent, and lymphoid 
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follicles were scattered in the periphery facing the renal parenchyma. C: Fibrosis 
and inflammation extend from the adipose tissue of the renal hilum into the renal 
parenchyma (*). D: Nerve bundles are intact. Note the perineural inflammation. 
E: Inflammation and hyalinized fibrosis are shown. F: Note the mild 
inflammation but prominent fibrosis.  
 
Figure 4. IgG4-related ureteral disease (Case 15 in Table 1). A: Semi-macroscopic 
image of the cross-section of the resected ureter. Distinct areas of prominent 
inflammation and fibrotic areas were found in the ureteral wall. Inflammation 
partially invades into adipose tissue of renal hilum (arrow). B: In inflammatory 
areas, a follicle-like inflammatory formation and extension of inflammation into 
the adipose tissue were found. C: Fibrosis was prominent, and sclerotic change 
was present; however, the inflammatory foci remained. D: Immunohistochemical 
staining for IgG4. Many IgG4-positive cells were found around the inflammatory 
area. E: Semi-serial section of the area shown in (D). Immunohistochemical 
staining for IgG1. Several scattered IgG1-positive cells, albeit in smaller numbers 
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Table 1   Clinical summary of reported cases of IgG4-related pelvic and uretheral lesions
Age (years) Sex Location of lesion
Case 1 63 Male Left renal pelvis
Case 2 49 Female Left renal pelvis to ureter
Case 3 76 Male Right renal pelvis to ureter
Case 4 61 Male Left renal pelvis
Case 5 70 Male Left renal pelvis + Right renal pelvis (metachronous)
Case 6 70s Male Left renal pelvis + Right renal pelvis (metachronous)
Case 7 70s Male Left renal pelvis to ureter
Case 8 65 Male Left renal pelvis
Case 9 78 Male Left renal pelvis + Right renal pelvis (metachronous)
Case 10 53 Male Bilateral renal pelvis
Case 11 60s Female Left renal pelvis
Case 12 52 Female Left renal pelvis
Case 13 59 Male Bilateral ureters
Case 14 51 Female Left ureter
Case 15 39 Male Left ureter
Case 16 60 Male Left ureter
Case 17 74 Male Right ureter
Case 18 75 Male Left ureter
Case 19 45 Male Left ureter (psudotumor)
Case 20 47 Male Left ureter (psudotumor)
Case 21 84 Female Right ureter ＋urothelial carcinoma (in situ)
Case 22 53 Female right renal pelvis
Case 23 69 Male Left renal pelvis+Right renal hilus (metachronous)
Case 24 49 Female Bilateral renal pelvis
Case 25 79 Female Ureter
Case 26 68 Male Right renal mass
Case 27 80 Male Right renal pelvis
Case 28 71 Male Left renal pelvis
Case 29 71 Male Right ureter + Left renal hilus (metachronous)
Case 30 54 Female Left renal pelvis
Case 31 49 Male Right ureter
Case 32 68 Male Bilateral renal pelvis to ureters
Case 33 70 Male Left renal pelvis to ureter
Case 34 82 Female Left ureter
Case 35 77 Male Left ureter
Blanks, to be specified 
Size of lesion Serum IgG4
40 × 30 × 25 mm within normal range (post-operative)
35 mm 555 mg/dl
33 mm 376 mg/dl
936 mg/dl




22 × 15 mm 404 mg/dl
Elevated
Elevated




15 × 7 × 7 mm
10 × 40 mm
20 mm
3250 mg/dl
30 mm (left renal pelvis) 847 mg/dl
469mg/dl
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